Question 1

What is AmbioPharm?

Accepted Answer

AmbioPharm is a Entity.

Question 2

How often does AmbioPharm appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was AmbioPharm first tracked by Ergen?

Accepted Answer

First tracked on May 27, 2026.

Question 4

When was AmbioPharm last mentioned in news?

Accepted Answer

Last active on May 27, 2026.

Question 5

What is AmbioPharm's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is AmbioPharm in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving AmbioPharm?

Accepted Answer

CordenPharma acquires AmbioPharm (May 27, 2026, 7 articles).

Question 8

How did the "CordenPharma acquires AmbioPharm" event impact AmbioPharm?

Accepted Answer

AmbioPharm is being acquired by CordenPharma, which will integrate its peptide manufacturing capabilities and facilities into CordenPharma's global network, allowing its shareholders to reinvest in the combined business.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.